Sensus SRT-100 Vision
Sensus Healthcare
- Home ›
- Radiotherapy ›
- Superficial Radiotherapy ›
- Sensus SRT-100 Vision
The SRT-100 Vision represents the latest advancement in superficial radiotherapy (the only FDA cleared IG-SRT) technology, combining the proven efficacy of the SRT-100 system with advanced high-frequency ultrasound capabilities. This innovative device, developed by Sensus Healthcare, offers enhanced precision and treatment planning, revolutionising the way dermatological conditions are treated.